Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Immunodiagnostics Market Forecast: What Value Will The Market Reach By 2030?
The immunodiagnostics market has demonstrated robust expansion in recent years. Its valuation is anticipated to grow from $24.32 billion in 2025 to $26.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. The market’s past development can be linked to factors such as the rising prevalence of infectious and chronic diseases, the enlargement of clinical laboratory networks, the increasing demand for early disease detection, a growing reliance on antibody-based diagnostics, and the widespread availability of standardized immunoassay technologies.
The immunodiagnostics market is anticipated to experience robust expansion over the coming years. It is projected to reach $35.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth during the projection period can be attributed to factors such as the greater acceptance of personalized diagnostics, increased capital allocation in automated laboratory settings, the broadening of point-of-care immunodiagnostics, the expanding incorporation of AI-based result interpretation, and a heightened emphasis on preventive healthcare screening. Key trends anticipated in this forecast timeframe encompass the widespread adoption of automated immunoassay analyzers, an escalating need for highly sensitive diagnostic examinations, the growing utilization of swift immunodiagnostic kits, the broadening of multiplex testing capacities, and improved integration of laboratory data management systems.
Get A Free Sample Report With In-Depth Market Insights:
Immunodiagnostics Market Growth Backed By Core Demand Fundamentals
The growing occurrence of chronic illnesses is anticipated to fuel the expansion of the immunodiagnostics market moving ahead. These are persistent health issues, like diabetes, heart disease, and arthritis, which typically develop gradually and demand continuous medical care and lifestyle adjustments to manage symptoms and avert further complications. Their rise is primarily linked to detrimental lifestyle choices, such as inadequate diet, lack of physical activity, and smoking, all of which elevate the likelihood of developing conditions including diabetes, heart disease, and obesity. Immunodiagnostics assist in diagnosing chronic diseases by precisely identifying biomarkers and immune responses related to these lasting health problems. This technology facilitates the prompt detection and observation of conditions like diabetes, autoimmune disorders, and cardiovascular issues, thereby improving patient care and aiding in opportune treatment choices. For example, data from June 2024, reported by the National Health Service, a UK-based government department, indicated that in 2023, 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes). This figure represented an 18% increase from 3,065,825 cases recorded in 2022. Consequently, the increasing frequency of chronic and infectious diseases is a significant driver for the growth of the immunodiagnostics market.
Immunodiagnostics Market Segment Analysis: What Are The Core Market Categories?
The immunodiagnostics market covered in this report is segmented –
1) By Product: Reagents And Consumables, Instruments
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, Other Technologies
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
4) By End User: Hospitals, Clinics, Diagnostic Laboratories
Subsegments:
1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates
2) By Instruments: Immunoassay Analyzers, ELISA Readers
Immunodiagnostics Market Growth Trends Reshaping The Competitive Landscape
Companies operating within the immunodiagnostics market are increasingly directing their efforts towards creating innovative solutions, including automated chemiluminescence immunoassays (CLIAs), to improve diagnostic accuracy, reduce the time required for testing, and enhance overall laboratory efficiency. Automated chemiluminescence immunoassays (CLIAs) are laboratory tests that leverage light-emitting chemical reactions and automation to swiftly and accurately detect particular proteins or antibodies in blood and other samples. For instance, in September 2025, DiaSorin S.p.A., an Italy-based diagnostics company, launched the LIAISON® TSH-R Ab assay for the assessment of autoimmune thyroid disorders. This assay features enhanced antibody specificity achieved through its double-bridge assay architecture, offers seamless integration into existing LIAISON analyzers to streamline laboratory workflows, and possesses CE-marked compatibility, supporting its deployment across various regulated regions.
Immunodiagnostics Market Company Landscape And Competitive Strategy
Major companies operating in the immunodiagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., bioMérieux SA, Sysmex Corporation, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Fujirebio Holdings Inc., Quidel Corporation, Luminex Corporation, Bio-Techne Corporation, PerkinElmer Inc., Merck KGaA, Gold Standard Diagnostics Corp., OraSure Technologies Inc., Immunodiagnostic Systems Holdings Plc (IDS)
View The Full Immunodiagnostics Market Report:
Immunodiagnostics Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the immunodiagnostics market in 2025. The regions covered in the immunodiagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
